Sodium in PDB 7nab: Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Protein crystallography data
The structure of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165, PDB code: 7nab
was solved by
Y.Chen,
W.D.Tolbert,
M.Pazgier,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
38.56 /
2.15
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
82.762,
85.241,
87.067,
90,
114.77,
90
|
R / Rfree (%)
|
18.5 /
23.9
|
Sodium Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
16;
Binding sites:
The binding sites of Sodium atom in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
(pdb code 7nab). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 16 binding sites of Sodium where determined in the
Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165, PDB code: 7nab:
Jump to Sodium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Sodium binding site 1 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 1 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na301
b:42.9
occ:1.00
|
O
|
H:HOH487
|
2.5
|
42.0
|
1.0
|
OD1
|
H:ASP86
|
2.7
|
36.6
|
1.0
|
NH1
|
H:ARG38
|
2.8
|
41.1
|
1.0
|
OH
|
H:TYR90
|
2.9
|
32.6
|
1.0
|
CD
|
H:ARG38
|
3.4
|
35.5
|
1.0
|
CG
|
H:ASP86
|
3.7
|
39.8
|
1.0
|
O
|
H:HOH417
|
3.8
|
43.7
|
1.0
|
CZ
|
H:ARG38
|
3.8
|
38.3
|
1.0
|
CA
|
H:ASP86
|
3.8
|
40.8
|
1.0
|
CZ
|
H:TYR90
|
3.9
|
32.2
|
1.0
|
CB
|
H:ASP86
|
3.9
|
34.8
|
1.0
|
NE
|
H:ARG38
|
4.0
|
37.3
|
1.0
|
CE2
|
H:TYR90
|
4.1
|
29.9
|
1.0
|
CE2
|
H:PHE63
|
4.2
|
35.5
|
1.0
|
NE1
|
H:TRP82
|
4.2
|
39.5
|
1.0
|
O
|
H:ASP86
|
4.5
|
32.9
|
1.0
|
CD2
|
H:PHE63
|
4.5
|
33.4
|
1.0
|
O
|
H:SER85
|
4.5
|
39.4
|
1.0
|
C
|
H:ASP86
|
4.6
|
36.6
|
1.0
|
CZ2
|
H:TRP82
|
4.7
|
30.8
|
1.0
|
CG
|
H:ARG38
|
4.7
|
34.0
|
1.0
|
CE
|
H:MET48
|
4.8
|
28.1
|
1.0
|
CE2
|
H:TRP82
|
4.8
|
38.6
|
1.0
|
OD2
|
H:ASP86
|
4.8
|
38.6
|
1.0
|
N
|
H:ASP86
|
4.8
|
43.4
|
1.0
|
CD2
|
H:HIS66
|
4.9
|
30.0
|
1.0
|
NH2
|
H:ARG38
|
5.0
|
36.7
|
1.0
|
|
Sodium binding site 2 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 2 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na302
b:46.4
occ:1.00
|
O
|
H:LEU45
|
2.6
|
31.3
|
1.0
|
O
|
L:HOH492
|
2.6
|
31.8
|
1.0
|
O
|
H:HOH472
|
3.2
|
39.4
|
1.0
|
C
|
H:LEU45
|
3.6
|
32.3
|
1.0
|
O
|
L:PHE98
|
3.7
|
31.3
|
1.0
|
CB
|
L:PHE98
|
4.1
|
28.3
|
1.0
|
CA
|
H:GLU46
|
4.3
|
36.2
|
1.0
|
CG
|
H:GLU46
|
4.3
|
36.9
|
1.0
|
N
|
H:GLU46
|
4.4
|
29.9
|
1.0
|
N
|
H:LEU45
|
4.4
|
32.4
|
1.0
|
C
|
L:PHE98
|
4.4
|
33.9
|
1.0
|
N
|
L:PHE98
|
4.5
|
31.6
|
1.0
|
CA
|
L:PHE98
|
4.6
|
32.8
|
1.0
|
CA
|
H:LEU45
|
4.6
|
29.0
|
1.0
|
O
|
H:HOH441
|
4.7
|
37.0
|
1.0
|
CB
|
H:GLU46
|
4.8
|
34.7
|
1.0
|
O
|
L:HOH472
|
4.8
|
48.4
|
1.0
|
O
|
L:GLY99
|
4.8
|
32.2
|
1.0
|
CD1
|
L:PHE98
|
5.0
|
31.9
|
1.0
|
|
Sodium binding site 3 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 3 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na303
b:30.0
occ:1.00
|
OE1
|
H:GLN81
|
2.7
|
50.2
|
1.0
|
OG1
|
H:THR68
|
3.1
|
36.0
|
1.0
|
O
|
H:GLN81
|
3.2
|
42.4
|
1.0
|
ND2
|
H:ASN82A
|
3.2
|
44.2
|
1.0
|
N
|
H:ASN82A
|
3.3
|
41.7
|
1.0
|
CG
|
H:ASN82A
|
3.5
|
49.8
|
1.0
|
CA
|
H:TRP82
|
3.7
|
40.1
|
1.0
|
C
|
H:TRP82
|
3.7
|
43.5
|
1.0
|
C
|
H:GLN81
|
3.8
|
44.0
|
1.0
|
OD1
|
H:ASN82A
|
3.9
|
45.9
|
1.0
|
CB
|
H:THR68
|
3.9
|
39.5
|
1.0
|
CD
|
H:GLN81
|
3.9
|
53.0
|
1.0
|
N
|
H:THR68
|
4.0
|
38.4
|
1.0
|
CB
|
H:ASN82A
|
4.0
|
43.4
|
1.0
|
N
|
H:TRP82
|
4.1
|
38.9
|
1.0
|
O
|
H:HIS66
|
4.2
|
48.5
|
1.0
|
CA
|
H:ASN82A
|
4.2
|
43.9
|
1.0
|
C
|
H:VAL67
|
4.4
|
40.0
|
1.0
|
O
|
H:HOH451
|
4.4
|
45.3
|
1.0
|
CA
|
H:VAL67
|
4.5
|
45.1
|
1.0
|
CA
|
H:THR68
|
4.6
|
36.6
|
1.0
|
O
|
H:TRP82
|
4.6
|
41.5
|
1.0
|
CB
|
H:GLN81
|
4.8
|
41.6
|
1.0
|
CG
|
H:GLN81
|
4.8
|
47.8
|
1.0
|
C
|
H:HIS66
|
4.8
|
47.5
|
1.0
|
NE2
|
H:GLN81
|
4.8
|
61.7
|
1.0
|
CA
|
H:GLN81
|
4.9
|
44.5
|
1.0
|
N
|
H:VAL67
|
5.0
|
43.4
|
1.0
|
|
Sodium binding site 4 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 4 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na301
b:44.5
occ:1.00
|
OG
|
L:SER14
|
2.5
|
43.8
|
1.0
|
O
|
L:HOH440
|
2.6
|
42.2
|
1.0
|
CB
|
L:SER14
|
3.5
|
40.5
|
1.0
|
CD
|
L:LYS107
|
3.5
|
47.0
|
1.0
|
CG
|
L:LYS107
|
3.8
|
47.4
|
1.0
|
CB
|
L:LYS107
|
3.9
|
40.0
|
1.0
|
OD2
|
L:ASP17
|
4.0
|
42.7
|
1.0
|
O
|
L:HOH418
|
4.2
|
32.5
|
1.0
|
N
|
L:SER14
|
4.2
|
39.8
|
1.0
|
CE
|
L:LYS107
|
4.5
|
58.0
|
1.0
|
CA
|
L:SER14
|
4.5
|
37.4
|
1.0
|
C
|
L:ALA13
|
4.8
|
40.4
|
1.0
|
CG
|
L:ASP17
|
4.8
|
41.5
|
1.0
|
OD1
|
L:ASP17
|
4.9
|
43.6
|
1.0
|
O
|
L:LYS107
|
5.0
|
38.2
|
1.0
|
|
Sodium binding site 5 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 5 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 5 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na302
b:41.7
occ:1.00
|
N
|
L:LYS39
|
2.8
|
28.9
|
1.0
|
O
|
L:ALA43
|
2.9
|
35.8
|
1.0
|
O
|
L:HOH412
|
3.1
|
42.1
|
1.0
|
O
|
L:HOH502
|
3.2
|
52.2
|
1.0
|
CB
|
L:LYS42
|
3.3
|
39.3
|
1.0
|
CA
|
L:GLN38
|
3.5
|
32.3
|
1.0
|
C
|
L:GLN38
|
3.6
|
33.7
|
1.0
|
CB
|
L:LYS39
|
3.7
|
35.4
|
1.0
|
CA
|
L:LYS39
|
3.8
|
31.6
|
1.0
|
O
|
L:HOH453
|
3.9
|
48.8
|
1.0
|
O
|
L:GLN37
|
3.9
|
31.3
|
1.0
|
C
|
L:ALA43
|
4.0
|
33.5
|
1.0
|
CG
|
L:LYS39
|
4.0
|
35.8
|
1.0
|
O
|
L:LYS39
|
4.0
|
34.4
|
1.0
|
NZ
|
L:LYS45
|
4.1
|
51.6
|
1.0
|
C
|
L:LYS42
|
4.2
|
37.0
|
1.0
|
CG
|
L:LYS42
|
4.3
|
43.8
|
1.0
|
N
|
L:GLN38
|
4.3
|
33.8
|
1.0
|
CG
|
L:GLN38
|
4.3
|
31.5
|
1.0
|
CA
|
L:LYS42
|
4.3
|
39.2
|
1.0
|
O
|
L:LYS42
|
4.4
|
34.5
|
1.0
|
C
|
L:LYS39
|
4.4
|
33.5
|
1.0
|
N
|
L:ALA43
|
4.4
|
35.7
|
1.0
|
CB
|
L:GLN38
|
4.4
|
33.1
|
1.0
|
C
|
L:GLN37
|
4.5
|
31.3
|
1.0
|
CD
|
L:LYS39
|
4.5
|
44.1
|
1.0
|
CA
|
L:PRO44
|
4.7
|
29.8
|
1.0
|
N
|
L:PRO44
|
4.7
|
32.4
|
1.0
|
O
|
L:HOH454
|
4.7
|
52.3
|
1.0
|
O
|
L:GLN38
|
4.8
|
33.3
|
1.0
|
CG
|
L:LYS45
|
4.8
|
46.4
|
1.0
|
CA
|
L:ALA43
|
4.8
|
35.2
|
1.0
|
C
|
L:PRO44
|
5.0
|
32.4
|
1.0
|
N
|
L:LYS45
|
5.0
|
31.0
|
1.0
|
|
Sodium binding site 6 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 6 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 6 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na303
b:50.3
occ:1.00
|
OG1
|
L:THR180
|
2.4
|
53.5
|
1.0
|
O
|
L:THR178
|
2.8
|
41.2
|
1.0
|
O
|
L:HOH510
|
2.9
|
44.9
|
1.0
|
CB
|
L:THR180
|
3.5
|
54.4
|
1.0
|
N
|
L:THR180
|
3.5
|
47.6
|
1.0
|
N
|
L:GLN160
|
3.6
|
42.8
|
1.0
|
C
|
L:THR178
|
3.7
|
38.7
|
1.0
|
CA
|
L:SER159
|
3.7
|
44.9
|
1.0
|
O
|
L:ASN158
|
3.7
|
48.4
|
1.0
|
C
|
L:SER159
|
3.9
|
45.2
|
1.0
|
CG
|
L:GLN160
|
4.1
|
45.1
|
1.0
|
CA
|
L:THR180
|
4.1
|
50.4
|
1.0
|
C
|
L:LEU179
|
4.1
|
44.8
|
1.0
|
CB
|
L:GLN160
|
4.2
|
41.3
|
1.0
|
CB
|
L:THR178
|
4.2
|
44.0
|
1.0
|
OE1
|
L:GLN160
|
4.2
|
44.2
|
1.0
|
CA
|
L:LEU179
|
4.3
|
44.3
|
1.0
|
CG2
|
L:THR178
|
4.3
|
42.0
|
1.0
|
N
|
L:SER159
|
4.3
|
48.1
|
1.0
|
N
|
L:LEU179
|
4.3
|
42.4
|
1.0
|
O
|
H:HOH440
|
4.4
|
48.5
|
1.0
|
C
|
L:ASN158
|
4.4
|
52.1
|
1.0
|
O
|
L:HOH431
|
4.5
|
46.9
|
1.0
|
CA
|
L:GLN160
|
4.5
|
42.6
|
1.0
|
CA
|
L:THR178
|
4.6
|
41.7
|
1.0
|
CD
|
L:GLN160
|
4.7
|
47.9
|
1.0
|
CG2
|
L:THR180
|
4.7
|
52.9
|
1.0
|
O
|
L:SER159
|
4.8
|
46.7
|
1.0
|
CB
|
L:SER159
|
4.9
|
45.5
|
1.0
|
|
Sodium binding site 7 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 7 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 7 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na304
b:51.6
occ:1.00
|
OG
|
L:SER93
|
2.4
|
43.3
|
1.0
|
O
|
L:HOH482
|
2.7
|
51.0
|
1.0
|
O
|
L:HOH429
|
2.7
|
34.3
|
1.0
|
O
|
L:PHE94
|
2.8
|
39.3
|
1.0
|
C
|
L:PHE94
|
3.5
|
35.9
|
1.0
|
CB
|
L:SER93
|
3.6
|
36.3
|
1.0
|
CG1
|
L:ILE2
|
3.7
|
43.5
|
1.0
|
O
|
L:SER93
|
3.8
|
34.3
|
1.0
|
C
|
L:SER93
|
3.8
|
35.5
|
1.0
|
CD1
|
L:ILE2
|
3.9
|
39.4
|
1.0
|
N
|
L:PHE94
|
4.1
|
36.6
|
1.0
|
N
|
L:PRO95
|
4.1
|
36.7
|
1.0
|
CD
|
L:PRO95
|
4.3
|
32.9
|
1.0
|
CA
|
L:SER93
|
4.3
|
37.9
|
1.0
|
CA
|
L:PHE94
|
4.4
|
35.2
|
1.0
|
N
|
L:ILE2
|
4.5
|
41.7
|
1.0
|
O
|
L:PRO95
|
4.6
|
29.9
|
1.0
|
CB
|
L:ILE2
|
4.8
|
35.4
|
1.0
|
NE2
|
L:GLN90
|
4.8
|
31.8
|
1.0
|
CA
|
L:GLU1
|
5.0
|
46.9
|
1.0
|
|
Sodium binding site 8 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 8 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 8 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na305
b:53.8
occ:1.00
|
O
|
L:GLN160
|
3.0
|
39.6
|
1.0
|
OG1
|
L:THR178
|
3.1
|
47.0
|
1.0
|
OG
|
L:SER176
|
3.2
|
37.7
|
1.0
|
O
|
L:SER176
|
3.6
|
38.3
|
1.0
|
O
|
H:HOH405
|
3.6
|
40.8
|
1.0
|
O
|
L:HOH470
|
3.6
|
42.2
|
1.0
|
N
|
L:THR178
|
3.7
|
36.1
|
1.0
|
C
|
L:GLN160
|
3.7
|
43.3
|
1.0
|
CB
|
L:THR178
|
3.8
|
44.0
|
1.0
|
O
|
H:HOH500
|
3.8
|
46.4
|
1.0
|
N
|
L:SER162
|
4.0
|
36.0
|
1.0
|
CA
|
L:GLU161
|
4.0
|
42.6
|
1.0
|
C
|
L:SER176
|
4.1
|
36.8
|
1.0
|
C
|
L:GLU161
|
4.1
|
38.2
|
1.0
|
O
|
H:HOH432
|
4.2
|
41.7
|
1.0
|
N
|
L:GLU161
|
4.2
|
44.4
|
1.0
|
CB
|
L:SER176
|
4.3
|
31.5
|
1.0
|
CA
|
L:SER177
|
4.3
|
37.2
|
1.0
|
C
|
L:SER177
|
4.3
|
38.8
|
1.0
|
CB
|
L:SER162
|
4.3
|
39.7
|
1.0
|
CA
|
L:THR178
|
4.4
|
41.7
|
1.0
|
N
|
L:SER177
|
4.4
|
36.1
|
1.0
|
CG1
|
H:VAL169
|
4.5
|
41.1
|
1.0
|
CG2
|
H:VAL169
|
4.6
|
43.5
|
1.0
|
CB
|
L:GLN160
|
4.7
|
41.3
|
1.0
|
CA
|
L:GLN160
|
4.7
|
42.6
|
1.0
|
O
|
L:GLU161
|
4.8
|
44.6
|
1.0
|
CA
|
L:SER162
|
4.8
|
37.3
|
1.0
|
CA
|
L:SER176
|
4.9
|
35.8
|
1.0
|
|
Sodium binding site 9 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 9 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 9 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na306
b:50.3
occ:1.00
|
OG1
|
L:THR109
|
2.5
|
35.1
|
1.0
|
NH2
|
L:ARG108
|
3.3
|
35.0
|
1.0
|
O
|
L:VAL110
|
3.4
|
38.2
|
1.0
|
CB
|
L:THR109
|
3.5
|
38.6
|
1.0
|
C
|
L:THR109
|
4.4
|
41.4
|
1.0
|
C
|
L:VAL110
|
4.5
|
37.5
|
1.0
|
CA
|
L:THR109
|
4.5
|
35.5
|
1.0
|
CG2
|
L:THR109
|
4.5
|
40.8
|
1.0
|
O
|
L:THR109
|
4.6
|
33.6
|
1.0
|
O
|
L:HOH441
|
4.6
|
50.9
|
1.0
|
CZ
|
L:ARG108
|
4.6
|
39.6
|
1.0
|
N
|
L:VAL110
|
4.8
|
38.2
|
1.0
|
|
Sodium binding site 10 out
of 16 in 7nab
Go back to
Sodium Binding Sites List in 7nab
Sodium binding site 10 out
of 16 in the Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 10 of Crystal Structure of Human Neutralizing Mab CV3-25 Binding to Sars- Cov-2 S Mper Peptide 1140-1165 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:Na307
b:30.0
occ:1.00
|
O
|
H:HOH464
|
3.6
|
39.3
|
1.0
|
CG
|
L:PHE94
|
3.7
|
36.6
|
1.0
|
CB
|
L:PHE94
|
3.8
|
35.4
|
1.0
|
CD2
|
L:PHE94
|
3.8
|
38.3
|
1.0
|
CD
|
H:ARG58
|
3.9
|
56.9
|
0.9
|
CB
|
H:ARG58
|
4.1
|
40.2
|
0.9
|
O
|
L:HOH522
|
4.2
|
41.5
|
1.0
|
CD1
|
L:PHE94
|
4.2
|
36.5
|
1.0
|
CE2
|
L:PHE94
|
4.4
|
41.8
|
1.0
|
CG
|
H:ARG58
|
4.6
|
48.7
|
0.9
|
O
|
H:TYR59
|
4.6
|
40.5
|
1.0
|
O
|
H:HOH527
|
4.7
|
54.4
|
1.0
|
CE1
|
L:PHE94
|
4.8
|
36.6
|
1.0
|
NE
|
H:ARG58
|
4.8
|
58.5
|
0.9
|
O
|
H:HOH447
|
4.9
|
49.5
|
1.0
|
CZ
|
L:PHE94
|
4.9
|
37.7
|
1.0
|
CA
|
H:ARG58
|
4.9
|
39.8
|
0.9
|
|
Reference:
I.Ullah,
J.Prevost,
M.S.Ladinsky,
H.Stone,
M.Lu,
S.P.Anand,
G.Beaudoin-Bussieres,
M.Benlarbi,
S.Ding,
R.Gasser,
C.Fink,
Y.Chen,
A.Tauzin,
G.Goyette,
C.Bourassa,
H.Medjahed,
M.Mack,
K.Chung,
C.B.Wilen,
G.A.Dekaban,
J.D.Dikeakos,
E.A.Bruce,
D.E.Kaufmann,
L.Stamatatos,
A.T.Mcguire,
J.Richard,
M.Pazgier,
P.J.Bjorkman,
W.Mothes,
A.Finzi,
P.Kumar,
P.D.Uchil.
Live Imaging of Sars-Cov-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function For Optimal Efficacy. Biorxiv 2021.
DOI: 10.1101/2021.03.22.436337
Page generated: Tue Oct 8 18:05:20 2024
|